Delsia press page
Delsia press page
What is the source of DELSIA’s funding? DELSIA operates exclusively on financial support provided through investments from Autism Speaks. Supplemental grants may also be approved to DELSIA by the Autism Speaks Board of Directors from time to time to act on unexpected opportunities.
Will DELSIA raise its own funds? Can donors give directly to DELSIA? No. Currently DELSIA does not accept financial gifts or donations, nor does it engage in fundraising activities to support its activities.
Who do we work with? DELSIA works with partners in the for-profit sector to fund development activities that are best positioned to deliver products aligned with the diverse unmet medical and behavioral health needs of the autism community.
What do we fund? DELSIA funding priorities target development opportunities in the following product categories:
President - Daniel G. Smith, Ph.D.
Dr. Smith holds a dual role as the president of DELSIA and senior director of discovery research at Autism Speaks. He oversees DELSIA’s strategy and operations and a research portfolio focused on diagnostics, biomarkers and therapeutic interventions for autism. Daniel joined Autism Speaks in 2012 after leading discovery research laboratories in the pharmaceutical sector, most recently as senior principal scientist and laboratory head in the Neuroscience Research Unit at Pfizer.
To transform lives by ensuring that scientific breakthroughs and technological advances move beyond the research laboratory and into the community in the form of products that improve health and quality of life for individuals with autism.
25 October 2012
NEW YORK, N.Y. (October 25, 2012) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced the formation of Delivering Scientific Innovation for Autism (DELSIA) an independent not-for-profit affiliate of Autism Speaks that will work directly with for-profit sector partners to stimulate the conversion of scientific research from the lab into products needed by both the autism and medical communities, more rapidly and effectively.